<!DOCTYPE html><html><head><title>R: Acute myeloid leukemia</title>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />
<link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/katex@0.15.3/dist/katex.min.css">
<script type="text/javascript">
const macros = { "\\R": "\\textsf{R}", "\\code": "\\texttt"};
function processMathHTML() {
    var l = document.getElementsByClassName('reqn');
    for (let e of l) { katex.render(e.textContent, e, { throwOnError: false, macros }); }
    return;
}</script>
<script defer src="https://cdn.jsdelivr.net/npm/katex@0.15.3/dist/katex.min.js"
    onload="processMathHTML();"></script>
<link rel="stylesheet" type="text/css" href="R.css" />
</head><body><div class="container"><main>

<table style="width: 100%;"><tr><td>myeloid</td><td style="text-align: right;">R Documentation</td></tr></table>

<h2>Acute myeloid leukemia</h2>

<h3>Description</h3>

<p>This simulated data set is based on a trial in acute myeloid
leukemia.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>myeloid
data(cancer, package="survival")
</code></pre>


<h3>Format</h3>

<p>A data frame with 646 observations on the following 9 variables.
</p>

<dl>
<dt><code>id</code></dt><dd><p>subject identifier, 1-646</p>
</dd>
<dt><code>trt</code></dt><dd><p>treatment arm A or B</p>
</dd>
<dt><code>sex</code></dt><dd><p>f=female, m=male</p>
</dd>
<dt><code>flt3</code></dt><dd><p>mutations of the FLT3 gene, a factor with levels
of A, B, C</p>
</dd>
<dt><code>futime</code></dt><dd><p>time to death or last follow-up</p>
</dd>
<dt><code>death</code></dt><dd><p>1 if <code>futime</code> is a death, 0 for censoring</p>
</dd>
<dt><code>txtime</code></dt><dd><p>time to hematropetic stem cell transplant</p>
</dd>
<dt><code>crtime</code></dt><dd><p>time to complete response</p>
</dd>
<dt><code>rltime</code></dt><dd><p>time to relapse of disease</p>
</dd>
</dl>



<h3>Details</h3>

<p>This data set is used to illustrate multi-state survival curves.
It is based on the actual study in the reference below.
A subset of subjects was de-identifed, reordered, and then all of the
time values randomly perturbed.
</p>
<p>Mutations in the FLT3 domain occur in about 1/3 of AML patients,
the additional agent in treatment arm B was presumed to target this anomaly.
All subjects had a FLT mutation, either internal tandem duplications (ITD)
(divided into low vs high) +- mutations in the TKD domain, or TKD mutations
only.  This was a stratification factor for treatment assignment in
the study.   The levels of A, B, C correspond to increasing severity of the
mutation burden.
</p>


<h3>References</h3>

<p>Le-Rademacher JG, Peterson RA, Therneau TM, Sanford BL, Stone RM,
Mandrekar SJ.  Application of multi-state models in cancer clinical trials. 
Clin Trials. 2018 Oct; 15 (5):489-498
</p>


<h3>Examples</h3>

<pre><code class='language-R'>coxph(Surv(futime, death) ~ trt + flt3, data=myeloid)
# See the mstate vignette for a more complete analysis
</code></pre>

</main>

</div>
</body></html>
